DECIT

DECIT is a biotechnology company focused on leveraging digital engineering and computational intelligence to accelerate drug discovery and clinical innovation. The company utilizes a proprietary platform that integrates high-throughput data with advanced machine learning algorithms to identify novel therapeutic targets and optimize drug candidates. DECIT's approach aims to bridge the gap between early-stage research and clinical application by providing data-driven insights into disease mechanisms and patient stratification. The company is currently developing a pipeline of programs across oncology, rare diseases, and autoimmune conditions, primarily in the pre-clinical stage. By combining engineering principles with biological expertise, DECIT seeks to transform the traditional drug development paradigm and improve outcomes for patients with complex diseases.